-+ 0.00%
-+ 0.00%
-+ 0.00%

CALIWAY ANNOUNCES POSITIVE PHASE 2 RESULTS OF CBL-514 IN DERCUM'S DISEASE, ACHIEVING PRIMARY ENDPOINT WITH STATISTICALLY SIGNIFICANT AND SUSTAINED PAIN REDUCTION

Reuters·09/23/2026 02:10:01

Veuillez vous connecter pour afficher les détails des actualités